All data are based on the daily closing price as of August 28, 2025
b

Bora Pharmaceuticals

6472.TW
24.03 USD
-0.02
-0.08%

Overview

Last close
24.03 usd
Market cap
2.44B usd
52 week high
28.88 usd
52 week low
18.84 usd
Target price
27.78 usd

Valuation

P/E
19.2996
Forward P/E
N/A
Price/Sales
4.2676
Price/Book Value
7.6148
Enterprise Value
3.43B usd
EV/Revenue
4.9127
EV/EBITDA
13.7437

Key financials

Revenue TTM
698.74M usd
Gross Profit TTM
266.99M usd
EBITDA TTM
138.46M usd
Earnings per Share
1.24 usd
Dividend
0.38 usd
Total assets
1.37B usd
Net debt
394.39M usd

About

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.
  • Symbol
    6472.TW
  • Exchange
    TW
  • Isin
    TW0006472004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Taipei
  • Web site
    https://www.bora-corp.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top